Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Expert Review of Molecular Diagnostics|August 12, 2014
Molecular diagnostics clinical utility strategy: a six-part frameworkFelix W Frueh, Bruce QuinnPharmacogenomics|July 17, 2009
Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicineFelix W FruehDrug Discovery Today|October 4, 2011
Considerations for safety pharmacogenetics in clinical practiceFelix W FruehTrends in Molecular Medicine|March 3, 2012
On rat poison and human medicines: personalizing warfarin therapyFelix W FruehPharmacogenomics|April 27, 2010
Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practiceFelix W FruehPersonalized Medicine|May 24, 2018
Considerations for a business model for the effective integration of novel biomarkers into drug developmentFelix W FruehValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United StatesFelix W FruehPharmacogenomics|June 24, 2004
From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the communityFelix W Frueh, David GurwitzEnvironmental and Molecular Mutagenesis|June 15, 2007
Implementing the U.S. FDA guidance on pharmacogenomic data submissionsFederico Goodsaid, Felix W FruehClinical Chemistry and Laboratory Medicine|May 16, 2003
The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: impact for diagnostics and pharmacogeneticsFelix W Frueh, Mario Noyer-WeidnerPageof 5